Consolidated Statements of Stockholders’ Equity - USD ($)	Preferred Stock	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at Dec. 31, 2019	$ 14	$ 206,569	$ 85,907,523	$ (89,036,271)	$ (2,922,165)
Balance (in Shares) at Dec. 31, 2019	13,602	206,569,062
Stock-based compensation expense			1,487,701		1,487,701
Restricted stock agreement-based non-cash compensation		$ 19	13,106		13,125
Restricted stock agreement-based non-cash compensation (in Shares)		18,750
Common stock issued on exercise of stock option and warrant		$ 1,075	74,175		75,250
Common stock issued on exercise of stock option and warrant (in Shares)		1,075,000
Sale of common stock		$ 5,480	1,638,620		1,644,100
Sale of common stock (in Shares)		5,480,334
Cancellation of common stock		$ (11,000)	11,000
Cancellation of common stock (in Shares)		(11,000,000)
Accrual of payment in anticipation of settlement		$ (25,000)	(1,475,000)		(1,500,000)
Accrual of payment in anticipation of settlement (in Shares)		(25,000,000)
Stock issuance to pay off convertible notes and accrued interest		$ 18,386	5,497,466		5,515,852
Stock issuance to pay off convertible notes and accrued interest (in Shares)		18,386,174
Purchase and cancellation of common stock		$ (5,000)	(295,000)		300,000
Purchase and cancellation of common stock (in Shares)		(5,000,000)
Recognize beneficial conversion feature			919,000		919,000
Net loss for the year ended				(3,230,494)	(3,230,494)
Balance at Dec. 31, 2020	$ 14	$ 190,529	93,778,591	(92,266,764)	1,702,369
Balance (in Shares) at Dec. 31, 2020	13,602	190,529,320
RSU restricted stock		$ 31	4,519		4,550
RSU restricted stock (in Shares)		31,250
Stock-based compensation			1,232,256		1,232,256
Common stock issued on cashless exercise of options and warrants		$ 4,084	(4,084)
Common stock issued on cashless exercise of options and warrants (in Shares)		4,082,637
Common stock issued on exercise of options and warrants		$ 1,650	106,350		108,000
Common stock issued on exercise of options and warrants (in Shares)		1,650,010
Common stock issued on exercised of convertible note		$ 158	47,340		47,498
Common stock issued on exercised of convertible note (in Shares)		158,329
Sale of common stock		$ 11,110	5,287,890		5,299,000
Sale of common stock (in Shares)		11,110,915
Net loss for the year ended				(5,425,453)	(5,425,453)
Balance at Dec. 31, 2021	$ 14	$ 207,562	$ 100,452,862	$ (97,692,217)	$ 2,968,221
Balance (in Shares) at Dec. 31, 2021	13,602	207,562,461